Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Sep 18 - Sep 23
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus (Mounjaro) and chronic weight management (Zepbound)
Published preclinical studies describe cytoprotection-associated, pro-migratory, angiogenesis-associated, endothelial, and tissue-repair-related endpoints observed in defined laboratory model systems
You will need a professional to guide you on administering the injection properly if you are starting this treatment
Some patients benefit from weekly therapy during high-stress seasons, while others transition to monthly treatments for maintenance
Induction of Schistosoma mansoni glutathione S-transferase by xenobiotics [PMID: 8489258] Laboratory literature summary: Induction of Schistosoma mansoni glutathione S-transferase by xenobiotics
